• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,714.15
    -230.75 (--0.41%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 109.09(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals - Multinational

  • MNC Asc-Glaxo
  • BSE Code : 195.0
  • ISIN : INE159A01016
3,254.00 -113 (-3.35%)
  • As on 17 Jun 2025 (EOD)

  • Today’s Low

    3,240.00

  • Today’s High

    3,356.70

  • Open

    3,344.00

  • Perv Close

    3,366.80

  • 52W Low

    1,921.00

  • 52W High

    3,515.70

Key Indicators

  • P/E(TTM)

    63.66

  • Mar.Cap (₹Cr.)

    55,124.72

  • Div & Yield %

    1.66

  • Book Value(₹)

    115.06

  • Debt-Equity Ratio

    -3.35

  • AGM Date

    17-Jun-2025

  • EPS

    51.09

  • P/E Ratio

    63.66

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    55,124.72

  • RONW (%)

    37.32

  • ROCE (%)

    44.97

Score Board

  • Equity (₹ in Cr.)

    169.41

  • BV (₹)

    115.10

  • Sales( ₹ in Cr.)

    3,723.49

  • NP (in Cr.)

    865.43

  • NP Var(%)

    33.0

  • Div%

    540.0

  • CPS (₹)

    55.00

  • EPS (₹)

    51.10

  • Traded Value (₹ in Lakhs)

    57,030.54

  • 52 Week High

    3,515.70

  • 52 Week Low

    1,921.00

  • Price BSE

    3367.0

  • Price NSE

    3,367.00

  • Market Capital( in Cr.)

    57,030.54

  • P/C Ratio

    61.20

  • P/E Ratio

    65.90

  • Price Vs.BV

    51.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 3,723.49 3,407.25 3,216.34 3,217.51 2,920.48 3,224.68
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,723.49 3,407.25 3,216.34 3,217.51 2,920.48 3,224.68
Other Income 147.26 143.17 114.96 1,423.27 217.71 624.37
Stock Adjustments -51.23 69.64 -67.25 -13.83 26.12 35.43
Total Income 3,819.52 3,620.06 3,264.05 4,626.95 3,164.31 3,884.48
EXPENDITURE :            
Raw Materials 1,315.97 1,358.07 1,182.78 1,281.91 1,275.49 1,343.30
Power and Fuel Cost 30.18 29.64 29.60 27.83 26.08 33.36
Employee Cost 579.70 624.39 594.99 610.23 616.16 628.55
Other Manufacturing Expenses 114.26 113.61 99.05 120.14 110.59 107.88
Selling and Administration Expenses 383.95 374.71 370.30 343.57 242.00 376.68
Miscellaneous Expenses 78.91 239.12 84.32 85.69 287.75 983.19
Employee Benefit Expenses 579.70 624.39 594.99 610.23 616.16 628.55
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,502.98 2,739.54 2,361.04 2,469.38 2,558.07 3,472.96
Operating Profit 1,316.54 880.52 903.01 2,157.57 606.24 411.52
Interest 1.31 1.80 1.81 1.99 3.53 6.34
Gross Profit 1,315.23 878.72 901.20 2,155.58 602.71 405.18
Depreciation 66.79 69.68 65.77 68.19 78.60 82.68
Profit Before Tax 1,248.44 809.04 835.43 2,087.39 524.11 322.50
Current Tax 323.18 235.71 246.05 407.36 158.67 260.17
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 6.20 -11.36 -18.37 -10.49 7.87 -47.72
Reported Net Profit 919.05 584.69 607.75 1,690.53 357.57 110.05
Extraordinary Items 53.61 -66.58 21.05 11.18 -117.79 -87.09
Adjusted Net Profit 865.44 651.27 586.70 1,679.35 475.36 197.14
Adjustment below Net Profit 0.00 0.00 -17.08 -11.05 0.00 -73.62
P & L Balance brought forward 870.71 828.12 1,745.02 562.71 882.77 1,177.99
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 745.39 542.10 1,524.66 508.22 677.62 338.81
P & L Balance carried down 1,044.37 870.71 811.03 1,733.98 562.71 875.62
Dividend 203.29 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 540.00 320.00 320.00 900.00 300.00 400.00
Dividend Per Share(Rs) 54.00 32.00 32.00 90.00 30.00 40.00
Earnings Per Share-Unit Curr 54.25 34.51 35.88 99.79 21.11 6.50
Earnings Per Share(Adj)-Unit Curr 54.25 34.51 35.88 99.79 21.11 6.50
Book Value 115.06 105.31 103.48 158.06 88.37 108.62
Book Value(Adj)-Unit Curr 115.06 105.31 103.48 158.06 88.37 108.62

Shareholding Pattern

  • Promoter Group

    75.00%

  • Public Share Holding

    25.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 127,054,524 75.00 127,054,524 4
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 127,054,524 75.00 127,054,524 4
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 6,304 0.00 6,304 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 18,328 0.01 11,364 18
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,654,731 4.52 7,654,693 255
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,366,548 2.58 4,366,548 11
Mutual Funds / UTI 8,752,415 5.17 8,738,995 36
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 53,294 0.03 40,410 17
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,851,620 12.31 20,818,314 340
2] Non Institution
Bodies Corporate 1,124,761 0.66 1,108,973 882
Clearing Members 5,494 0.00 5,494 5
Directors of their Relatives 600 0.00 600 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 820,498 0.48 811,343 3,901
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 437,378 0.26 437,378 2,272
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 680,250 0.40 680,250 14
Individuals holding nominal share capital up to Rs. 1 lakh 17,276,256 10.20 16,081,417 114,440
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 92,849 0.05 92,849 25
Others 1,061,804 0.63 1,061,804 1
Sub Total 21,499,890 12.69 20,280,108 121,541
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 169,406,034 100.00 168,152,946 121,885

Company Background

Glaxosmithkline Pharmaceuticals LtdPharmaceuticals - Multinational

  • Glaxosmithkline Pharmaceuticals Ltd
  • BSE Code : 195.0
  • ISIN : INE159A01016

  • Incorporation Year

    1924

  • Registered Office

    GSK House
    Dr Annie Besant Road Worli, Mumbai,
    Maharashtra-400030

  • Telephone

    91-022-24959595

  • FAX

    91-022-24959494

  • Chairman

    Renu S Karnad

  • Managing Director

    Bhushan Akshikar

  • Company Secretary

    A A Nadkarni

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Glaxosmithkline Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Glaxosmi. Pharma 3,252.30 3,866.05 3,723.49 59.95 58.72
Abbott India 31,803.35 6,097.18 5,848.91 47.78 44.71
Astrazeneca Phar 10,081.60 1,330.33 1,295.53 217.75 33.26
P & G Health Ltd 5,907.05 1,166.89 1,151.26 39.04 39.76
Cipla 1,503.50 17,645.00 16,574.34 23.54 20.10
Novartis India 1,005.10 396.75 335.07 24.59 15.57
Amrutanjan Healt 708.25 437.58 421.23 40.29 20.84
Guj. Themis Bio. 337.05 174.19 169.82 75.23 44.82
Fermenta Biotec. 334.25 315.24 307.09 14.55 4.10
Bliss GVS Pharma 141.95 638.96 605.46 21.67 11.19
Ambalal Sarabhai 36.76 11.70 3.81 34.04 1.92